Progressive Supranuclear Palsy (PSP) is a rare neurological condition that occurs due to damage to nerve cells in the brain that are associated with movement. It affects muscles of the limbs, eyes, and in advanced stages heart and respiratory system.
Last year alone, ophthalmologists performed more than 8 million anti-VEGF injections in the United States.
Researchers have been searching for a better alternative to monthly injections almost from the moment anti-VEGFs were introduced. Gene therapy is emerging as one of the more promising alternatives to long-term anti-VEGF treatment.